A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration.
Researchers at Michigan Medicine have developed a new biomarker-based technique to screen for a rare and fatal consequence caused by monoclonal antibodies, which are used to treat a variety of tumours.
Stressed university students might want to add walnuts to their daily diet in the weeks leading up to their next exam. A new clinical trial of undergraduate students during their university studies has shown positive effects of walnut consumption on self-reported measures of mental health an
The study has revealed that multiple blood biomarkers were sufficient in identifying Alzheimer's disease pathology, even in participants with no symptoms.
Melanoma is the fifth most common cancer in men and the seventh most common cancer in women. It is estimated that 68,130 people in the United States were diagnosed in 2010, and 8,700 died.
ADHD is one of the most common neurodevelopmental disorders in childhood. Researchers discovered biomarkers by analyzing data from MRI exams on nearly 8,000 children.
Patients with acute COVID-19 infection have higher amounts of the cytokine IL-26 in their blood, according to researchers at Sweden's Karolinska Institutet. Furthermore, high IL-26 levels are associated with an increased inflammatory response, which indicates severe cases of the disease. The
Researchers at Mount Sinai's Icahn School of Medicine in New York discovered 35 genes that are overly expressed in people with chronic Lyme disease. These genes could be used as biomarkers to diagnose patients with the condition, which is currently difficult to treat.
While vaccines are one of the most powerful public health tools for protecting against infectious disease, not everybody is conferred the same level of protection. Many factors determine whether an individual responding to vaccination will generate an effective response, including specific b
Many factors determine whether an individual responding to vaccination will generate an effective response, including specific biomarkers within a person's immune system.
Washington [US], October 20 (ANI): Scientists at Swansea University who are developing a platform that would use Artificial Intelligence to speed up the process of detecting biomarkers in biofluids have shown that the concept could work.